Andrew Miller

Identifying and treating specific clinical outcomes like anhedonia in depression is the next step in developing targeted therapies in psychiatry…Unfortunately, this will be a challenge with many failures along the way…#Depresion #MentalHealth nam11.safelinks.protection.outlook.com/?url=https%3A%…

Advancing an Inflammatory Subtype of Depression. The time has come to disentangle the heterogeneity of depression and develop targeted therapies for mechanism-based entities. Read more at news.emory.edu/stories/2025/0… #depression #mentalhealth #PNIRS2025

@BIEmory The time has come to include inflammation as a specifier for major depression in the Sixth Edition of the DSM. #mentalhealth #depression jamanetwork.com/journals/jamap…

Immunopsychiatry can lead the way for targeted treatments and precision medicine in psychiatry...Check out a recent paper summarizing our discussions from an international forum in Crans-Montana, Switzerland... authors.elsevier.com/a/1kTwG3AAzzor… #depression #inflammation #mentalhealth

Work package 6 is being led by @AndyMillerLab, @MondelliValeria, Prof. Dan Stein, @LeboyerMarion and @BiopsyLab, who are are leading a 12-week study to test our decision tool for people with #depression who aren't responding to #antidepressants. Exciting steps ahead!🧠

Congrats Dionna Williams @DWWilliamsLab @EmoryMedicine -- and way to go towards paving a path of inspiration! @EmoryUniversity #Neuroscience #HIV #Research @ScienceNews sciencenews.org/article/dionna…

@BenedettaVai & @LiviaDePicker are leading work package 1 in groundbreaking #research on #inflammation related clinical predictors. They are performing a systematic review and meta-analysis to look at previous results and uncover new insights.

In work package 4, led by Francesco Benedetti & Jennifer Felger, we’re investigating if brain scans can predict how #depression patients respond to anti-inflammatory treatments! By analysing data from three trials, we aim to uncover brain markers linked to #inflammation.

Exciting work ahead with @LamersFemke and @Lombardo_GG leading WP3! They’ll explore how blood biomarkers can predict clinical improvement in #depression after #antiinflammatory treatment through meta-analysis.

New study demonstrates that blocking inflammation can reverse motivational deficits through effects on brain circuits . Check it out: news.emory.edu/stories/2024/0… #depression #mentalhealth #inflammation

Our team is busy building strong links between work packages to ensure every step of the process leads to meaningful results! 🔬✨ Have a look at our #PlanofWork with our pathways of #impact:

More data on the link between depression and inflammation. The time has come for an inflammation specifier for depression. Check this out medscape.com/viewarticle/mo… #inflammation #mentalhealth #depression

As illustrated, the #PNIRS24 sign was a hit among banquet-goers 😉

A fantastic end to #PNIRS24 🎆🎇🎆 Congrats to Jennifer Felger on delivering such an impactful Solomon award lecture!

Genevieve Craig and @MandyBekhbat present their work in depression #PNIRS24

Inflammation, Glia, and Glutamate converge to drive both Depression and Neurodegeneration: Check out Dr. Ebrahim Haroon's full talk here: vumedi.com/video/sobp-202…

Our work featured on PBS “Your Fantastic Mind”…Check it out…youtu.be/wuhB4HlHOXY?si… #depression #inflammation #mentalhealth

New findings from Emory study offer potential breakthrough in HIV cure research | Emory University | Atlanta GA news.emory.edu/stories/2023/0… @GavegnanoGroup @MonicaReece @drugbuster21 @CarlosdelRio7 @Boghuma

A sixth person, dubbed the “Geneva patient,” may be free of HIV after receiving a stem cell transplant intended to treat another disease—his cancer. Is an anti-inflammatory drug behind his recovery, instead? wired.trib.al/8VOWdrB